Brind.

ADMA Biologics, Inc. filed a lawsuit and was listed on the Nasdaq stock exchange.

7 reports, 4 independent Updated Jul 8
Gone quiet
Reports
7
Developments
5
Repetition
29%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

ADMA Biologics, Inc. filed a lawsuit and was listed on the Nasdaq stock exchange.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. ADMA Biologics listed on Nasdaq and filed a lawsuit in the US District Court.1 source
  2. ADMA Biologics listed on exchange after lawsuit filing.1 source
  3. ADMA Biologics faces a lawsuit in US District Court while trading on Nasdaq.1 source
  4. ADMA Biologics, Inc. is listed on the Nasdaq exchange.1 source
  5. ADMA Biologics listed on Nasdaq and faced a lawsuit.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped